secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2026-06-17T20:05:14+00:00
Accession:  0001837607-26-000046
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma stockholders elect Marc Forth and Seongsoo Park as Class III directors, ratify KPMG as auditor
--------------------------------------------------------------------------------

- Marc Forth elected with 13,297,322 votes for, 27,738 withheld; Seongsoo Park with 13,117,299 for, 207,761 withheld.
- Ratification of KPMG LLP as independent auditor for FY2026 passed with 21,502,418 votes for, 18,217 against, 1,498 abstain.
- Broker non-votes of 8,197,073 on director elections due to discretionary voting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000046/0001837607-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000046/aeon-20260617x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer